These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 31790940)

  • 61. Characterization and treatment of spontaneous recurrent seizures following nerve agent-induced status epilepticus in mice.
    McCarren HS; Eisen MR; Nguyen DL; Dubée PB; Ardinger CE; Dunn EN; Haines KM; Santoro AN; Bodner PM; Ondeck CA; Honnold CL; McDonough JH; Beske PH; McNutt PM
    Epilepsy Res; 2020 May; 162():106320. PubMed ID: 32182542
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of Newer Anticonvulsants for the Treatment of Status Epilepticus.
    Farrokh S; Bon J; Erdman M; Tesoro E
    Pharmacotherapy; 2019 Mar; 39(3):297-316. PubMed ID: 30723940
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Status epilepticus induction has prolonged effects on the efficacy of antiepileptic drugs in the 6-Hz seizure model.
    Leclercq K; Kaminski RM
    Epilepsy Behav; 2015 Aug; 49():55-60. PubMed ID: 26123104
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparing the efficacy of sodium valproate and levetiracetam following initial lorazepam in elderly patients with generalized convulsive status epilepticus (GCSE): A prospective randomized controlled pilot study.
    Nene D; Mundlamuri RC; Satishchandra P; Prathyusha PV; Nagappa M; Bindu PS; Raghavendra K; Saini J; Bharath RD; Thennarasu K; Taly AB; Sinha S
    Seizure; 2019 Feb; 65():111-117. PubMed ID: 30682680
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus.
    Choi JY; Hong JM; Kim TJ; Kim BG; Huh K
    Clin Neurol Neurosurg; 2019 Sep; 184():105454. PubMed ID: 31376771
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center.
    Synowiec AS; Yandora KA; Yenugadhati V; Valeriano JP; Schramke CJ; Kelly KM
    Epilepsy Res; 2012 Feb; 98(2-3):232-7. PubMed ID: 22000869
    [TBL] [Abstract][Full Text] [Related]  

  • 67. (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.
    Höfler J; Rohracher A; Kalss G; Zimmermann G; Dobesberger J; Pilz G; Leitinger M; Kuchukhidze G; Butz K; Taylor A; Novak H; Trinka E
    CNS Drugs; 2016 Sep; 30(9):869-76. PubMed ID: 27465262
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Propofol treatment of refractory status epilepticus: a study of 31 episodes.
    Rossetti AO; Reichhart MD; Schaller MD; Despland PA; Bogousslavsky J
    Epilepsia; 2004 Jul; 45(7):757-63. PubMed ID: 15230698
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A "malignant" variant of status epilepticus.
    Holtkamp M; Othman J; Buchheim K; Masuhr F; Schielke E; Meierkord H
    Arch Neurol; 2005 Sep; 62(9):1428-31. PubMed ID: 16157750
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Refractory status epilepticus.
    Murthy JM
    Neurol India; 2006 Dec; 54(4):354-8. PubMed ID: 17114841
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Detection and treatment of refractory status epilepticus in the intensive care unit.
    Drislane FW; Lopez MR; Blum AS; Schomer DL
    J Clin Neurophysiol; 2008 Aug; 25(4):181-6. PubMed ID: 18677181
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Refractory status epilepticus in children with and without prior epilepsy or status epilepticus.
    Sánchez Fernández I; Jackson MC; Abend NS; Arya R; Brenton JN; Carpenter JL; Chapman KE; Gaillard WD; Gaínza-Lein M; Glauser TA; Goldstein JL; Goodkin HP; Helseth A; Kapur K; McDonough TL; Mikati MA; Peariso K; Riviello J; Tasker RC; Topjian AA; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2017 Jan; 88(4):386-394. PubMed ID: 28011930
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Changes in Real-world Practice Patterns of Antiepileptic Drugs for Status Epilepticus: A Nationwide Observational Study in Japan.
    Nakamura K; Ohbe H; Matsui H; Takahashi Y; Marushima A; Inoue Y; Fushimi K; Yasunaga H
    Neurol Med Chir (Tokyo); 2020 Mar; 60(3):156-163. PubMed ID: 32009125
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acute withdrawal of new-generation antiepileptic drugs in epilepsy monitoring units: Safety and efficacy.
    Chou CC; Lin PT; Yen DJ; Yu HY; Kwan SY; Chen C; Liu YT; Shih YC; Lin SY
    Epilepsy Behav; 2021 Apr; 117():107846. PubMed ID: 33626492
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognosis of status epilepticus in elderly patients.
    Vilella L; González Cuevas M; Quintana Luque M; Toledo M; Sueiras Gil M; Guzmán L; Salas Puig J; Santamarina Pérez E
    Acta Neurol Scand; 2018 Mar; 137(3):321-328. PubMed ID: 29168175
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intravenous levetiracetam treatment in status epilepticus: A prospective study.
    Atmaca MM; Orhan EK; Bebek N; Gurses C
    Epilepsy Res; 2015 Aug; 114():13-22. PubMed ID: 26088881
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome.
    Esaian D; Joset D; Lazarovits C; Dugan PC; Fridman D
    Ann Pharmacother; 2013 Nov; 47(11):1569-76. PubMed ID: 24259603
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of Home Anticonvulsant Administration for Second-Line Status Epilepticus Treatment.
    Wabl R; Terman SW; Kwok M; Elm J; Chamberlain J; Silbergleit R; Hill CE
    Neurology; 2021 Aug; 97(7):e720-e727. PubMed ID: 34187862
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Factors associated with treatment delays in pediatric refractory convulsive status epilepticus.
    Sánchez Fernández I; Gaínza-Lein M; Abend NS; Anderson AE; Arya R; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Helseth AR; Jackson MC; Kapur K; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello JJ; Tasker RC; Tchapyjnikov D; Topjian AA; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2018 May; 90(19):e1692-e1701. PubMed ID: 29643084
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care.
    Prisco L; Ganau M; Aurangzeb S; Moswela O; Hallett C; Raby S; Fitzgibbon K; Kearns C; Sen A
    Seizure; 2020 Feb; 75():153-164. PubMed ID: 31623937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.